172 related articles for article (PubMed ID: 36285644)
21. [YAP1 knockdown suppresses the proliferation, migration and invasion of human nasopharyngeal carcinoma cells].
Zhou Y; Yang R; Ma G
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Mar; 39(3):286-291. PubMed ID: 31068306
[TBL] [Abstract][Full Text] [Related]
22. Transglutaminase 2 Binds to the CD44v6 Cytoplasmic Domain to Stimulate CD44v6/ERK1/2 Signaling and Maintain an Aggressive Cancer Phenotype.
Chen X; Adhikary G; Newland JJ; Xu W; Keillor JW; Weber DJ; Eckert RL
Mol Cancer Res; 2023 Sep; 21(9):922-932. PubMed ID: 37227250
[TBL] [Abstract][Full Text] [Related]
23. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA
Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692
[TBL] [Abstract][Full Text] [Related]
24. Cancer upregulated gene (CUG)2 elevates YAP1 expression, leading to enhancement of epithelial-mesenchymal transition in human lung cancer cells.
Kaowinn S; Yawut N; Koh SS; Chung YH
Biochem Biophys Res Commun; 2019 Mar; 511(1):122-128. PubMed ID: 30771899
[TBL] [Abstract][Full Text] [Related]
25. SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma.
Chai Y; Li Q; Zhao H; Zhang Z; Yu X; Pang L; Liu Z; Zhao J; Wang L; Li F
Cancer Med; 2019 Nov; 8(16):7055-7064. PubMed ID: 31560173
[TBL] [Abstract][Full Text] [Related]
26. Up-regulated acylglycerol kinase (AGK) expression associates with gastric cancer progression through the formation of a novel YAP1-AGK-positive loop.
Huang S; Cao Y; Guo H; Yao Y; Li L; Chen J; Li J; Xiang X; Deng J; Xiong J
J Cell Mol Med; 2020 Oct; 24(19):11133-11145. PubMed ID: 32827244
[TBL] [Abstract][Full Text] [Related]
27. LncRNA FLVCR1-AS1 mediates miR-513/YAP1 signaling to promote cell progression, migration, invasion and EMT process in ovarian cancer.
Yan H; Li H; Silva MA; Guan Y; Yang L; Zhu L; Zhang Z; Li G; Ren C
J Exp Clin Cancer Res; 2019 Aug; 38(1):356. PubMed ID: 31412903
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-345 suppresses cell invasion and migration in non-small cell lung cancer by directly targeting YAP1.
Zhang MY; Lin J; Kui YC
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2436-2443. PubMed ID: 30964169
[TBL] [Abstract][Full Text] [Related]
29. Sulforaphane inhibits PRMT5 and MEP50 function to suppress the mesothelioma cancer cell phenotype.
Ezeka G; Adhikary G; Kandasamy S; Friedberg JS; Eckert RL
Mol Carcinog; 2021 Jul; 60(7):429-439. PubMed ID: 33872411
[TBL] [Abstract][Full Text] [Related]
30. Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis.
Szulzewsky F; Arora S; Hoellerbauer P; King C; Nathan E; Chan M; Cimino PJ; Ozawa T; Kawauchi D; Pajtler KW; Gilbertson RJ; Paddison PJ; Vasioukhin V; Gujral TS; Holland EC
Genes Dev; 2020 Aug; 34(15-16):1051-1064. PubMed ID: 32675324
[TBL] [Abstract][Full Text] [Related]
31. ERK1 indicates good prognosis and inhibits breast cancer progression by suppressing YAP1 signaling.
Yu S; Zhang M; Huang L; Ma Z; Gong X; Liu W; Zhang J; Chen L; Yu Z; Zhao W; Liu Y
Aging (Albany NY); 2019 Dec; 11(24):12295-12314. PubMed ID: 31848326
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic Hedgehog-Smoothened Signaling Depends on YAP1‒TAZ/TEAD Transcription to Restrain Differentiation in Basal Cell Carcinoma.
Yuan Y; Salinas Parra N; Chen Q; Iglesias-Bartolome R
J Invest Dermatol; 2022 Jan; 142(1):65-76.e7. PubMed ID: 34293352
[TBL] [Abstract][Full Text] [Related]
33. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
He W; Zhang Y; Xia S
Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
[TBL] [Abstract][Full Text] [Related]
34. Loss of HACE1 promotes colorectal cancer cell migration via upregulation of YAP1.
Zhou Z; Zhang HS; Zhang ZG; Sun HL; Liu HY; Gou XM; Yu XY; Huang YH
J Cell Physiol; 2019 Jun; 234(6):9663-9672. PubMed ID: 30362561
[TBL] [Abstract][Full Text] [Related]
35. TRG-AS1 is a potent driver of oncogenicity of tongue squamous cell carcinoma through microRNA-543/Yes-associated protein 1 axis regulation.
He S; Wang X; Zhang J; Zhou F; Li L; Han X
Cell Cycle; 2020 Aug; 19(15):1969-1982. PubMed ID: 32615889
[TBL] [Abstract][Full Text] [Related]
36. YAP1 Regulates OCT4 Activity and SOX2 Expression to Facilitate Self-Renewal and Vascular Mimicry of Stem-Like Cells.
Bora-Singhal N; Nguyen J; Schaal C; Perumal D; Singh S; Coppola D; Chellappan S
Stem Cells; 2015 Jun; 33(6):1705-18. PubMed ID: 25754111
[TBL] [Abstract][Full Text] [Related]
37. miR-138 suppresses the proliferation of oral squamous cell carcinoma cells by targeting Yes-associated protein 1.
Xu R; Zeng G; Gao J; Ren Y; Zhang Z; Zhang Q; Zhao J; Tao H; Li D
Oncol Rep; 2015 Oct; 34(4):2171-8. PubMed ID: 26239136
[TBL] [Abstract][Full Text] [Related]
38. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.
Kang R; Yao DF; Xu GZ; Zhou YH
Neoplasma; 2020 Sep; 67(5):1094-1105. PubMed ID: 32538668
[TBL] [Abstract][Full Text] [Related]
39. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
40. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
Kang W; Tong JH; Chan AW; Lee TL; Lung RW; Leung PP; So KK; Wu K; Fan D; Yu J; Sung JJ; To KF
Clin Cancer Res; 2011 Apr; 17(8):2130-9. PubMed ID: 21346147
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
